162 Results for "

PDE5

" in MedChemExpress (MCE) Product Catalog:
Products (162)

162 Results for "PDE5" in MCE Product Catalog:

Cat. No.: HY-147991
CAS No.: 2414921-48-3
Research Areas:  

Cancer

PDE5/HDAC-IN-1 (Compound 26) is a potent phosphodiesterase 5 (PDE5) and HDAC inhibitor with IC50 values of 46.3 nM and 14.5 nM, respectively. PDE5/HDAC-IN-1 induces cell apoptosis and shows anticancer activities .
loading...
    loading...
Cat. No.: HY-121381
CAS No.: 34981-25-4
Purity:  ≥98.0%
Kuraridine is a prenylated flavonol extract from the roots of Sophora flavescens. Kuraridine has an inhibitory effect on cGMP specific phosphodiesterase type 5 (PDE5) (IC50=0.64 μM) .
loading...
    loading...
Cat. No.: HY-117605R
CAS No.: 139755-82-1
Synonyms: Desmethylsildenafil (Standard); UK-103,320 (Standard)
N-Desmethyl Sildenafil (Standard) is the analytical standard of N-Desmethyl Sildenafil. This product is intended for research and analytical applications. N-Desmethyl Sildenafil (Desmethylsildenafil) is a major metabolite of Sildenafil. Sildenafil is a potent phosphodiesterase type 5 (PDE5) inhibitor .
loading...
    loading...
Cat. No.: HY-W705784A
CAS No.: 212500-03-3
Research Areas:  

Endocrinology

T-1032 is a selective phosphodiesterase 5 (PDE5) inhibitor with an IC50 value of 1.0 nM. T-1032 shows relaxant effect on isolated rabbit corpus cavernosum. T-1032 can be used for the research of erectile dysfunction .
loading...
    loading...
Cat. No.: HY-179053
P2Y12/PDE5-IN-1 (Compound 10) is a dual-target inhibitor of P2Y12 (IC50 = 0.271 μg/mL) and PDE5 (IC50 = 0.154 μg/mL). P2Y12/PDE5-IN-1 can be used for research on anti-thrombosis and vasodilation .
loading...
    loading...
Cat. No.: HY-112704
CAS No.: 2244517-61-9
Research Areas:  

Cardiovascular Disease

PDE5-IN-2 is a potent, highly selective, and orally active PDE5 inhibitor, with an IC50 of 0.31 nM, less potently inhibits PDE2A, PDE10A, PDE4D2, and PDE6C, with IC50s of 106, 46, 43, 1.2 nM, respectively. Anti-pulmonary arterial hypertension activity .
loading...
    loading...
Cat. No.: HY-136520A
CAS No.: 247568-68-9
Research Areas:  

Metabolic Disease

(R)-Xanthoanthrafil is a phosphodiesterase-5 (PDE5) inhibitor. (R)-Xanthoanthrafil selectively inhibits PDE5, increasing cyclic guanosine monophosphate (cGMP) levels, leading to smooth muscle relaxation and promoting penile erection. (R)-Xanthoanthrafil can be used to study erectile dysfunction .
loading...
    loading...
Cat. No.: HY-W099761
CAS No.: 139756-22-2
Research Areas:  

Cardiovascular Disease

Sildenafil chlorosulfonyl is a synthetic intermediate in the synthesis of the phosphodiesterase 5 (PDE5) inhibitor Sildenafil (HY-15025).
loading...
    loading...
Cat. No.: HY-119611
CAS No.: 220060-39-9
Synonyms: KF31327 free base
Research Areas:  

Metabolic Disease Endocrinology

Thioquinapiperifil (KF31327 free base), a potent, selective and non-competitive phosphodiesterase-5 (PDE-5, IC50 of 0.074 nM) inhibitor, is used for sexual enhancement study .
loading...
    loading...
Cat. No.: HY-107191
CAS No.: 1308285-21-3
Research Areas:  

Cancer

Sildenafil Mesylate is an orally active and selective phosphodiesterase type 5 (PDE5) inhibitor. Sildenafil Mesylate can be used in studies of erectile dysfunction and cancer .
loading...
    loading...
Cat. No.: HY-153766
CAS No.: 157862-84-5
Purity:  ≥98.0%
Research Areas:  

Cardiovascular Disease

PDE5-IN-9 (Compound 59) is a PDE5 inhibitor (IC50: 11.2 μM). PDE5-IN-9 shows interaction with Gln 817, Tyr 612, and Ala 767 amino acid residues. PDE5-IN-9 can be used for research of cardiovascular disease .
loading...
    loading...
Cat. No.: HY-128060
CAS No.: 936449-28-4
Research Areas:  

Cardiovascular Disease

PDE5-IN-42 (Compound 42) is a potent and orally active PDE5 inhibitor with an IC50 of 0.04 nM. PDE5-IN-42 maintains selectivity over PDE6 and PDE11 .
loading...
    loading...
Cat. No.: HY-161290
Research Areas:  

Cardiovascular Disease

PDE5-IN-12 (compound 4h) is a potent phosphodiesterase-5 (PDE-5) inhibitor with an IC50 of 22 nM. PDE5-IN-12 shows anti-proliferative effects against the aortic cell line .
loading...
    loading...
Cat. No.: HY-90009B
CAS No.: 171596-27-3
Synonyms: 12-epi-IC-351
Research Areas:  

Cardiovascular Disease

12-epi-Tadalafil is a PDE5 inhibitor (IC50: 0.09 μM). 12-epi-Tadalafil can be used for research of cardiovascular diseases .
loading...
    loading...
Cat. No.: HY-149661
Research Areas:  

Cardiovascular Disease

PDE5-IN-11 is a potent inhibitor of PDE5 with an IC50 of 40 nM. PDE5-IN-11 also inhibits PDE4 and PDE6 with IC50s of 1.78 and 0.09 μM, respectively .
loading...
    loading...
Cat. No.: HY-155687
Research Areas:  

Neurological Disease

PDE5-IN-10 (compound 4b) is a potent PDE5 inhibitor with an IC50 of 20 nM. PDE5-IN-10 improves in vitro microsomal stability (t1/2 = 44.6 min) as well as excellent efficacy in restoring long-term potentiation. PDE5-IN-10 can be used for Alzheimer’s disease (AD) research .
loading...
    loading...
Cat. No.: HY-14841
CAS No.: 334826-98-1
Synonyms: UK-369003
Research Areas:  

Neurological Disease

Gisadenafil (UK-369003) is a specific, orally active phosphodiesterase 5 (PDE5) inhibitor with an IC50 of 3.6 nM and prevents degradation of cyclic guanosine monophosphate (cGMP) .
loading...
    loading...
Cat. No.: HY-176235
PDE5-IN-14 (Compound 14a) is a brain-penetrant competitive phosphodiesterase 5 (PDE5) inhibitor (IC50=16.11 nM). PDE5-IN-14 is promising for research of Alzheimer’s disease (AD), cancer and cardiovascular diseases .
loading...
    loading...
Cat. No.: HY-170435
Research Areas:  

Cardiovascular Disease

PDE5-IN-13 (Compound 14b) inhibits phosphodiesterase 5 (PDE5A) with an IC50 of 3 nM. PDE5-IN-13 is a potential candidate for PAH (pulmonary arterial hypertension) research. PDE5-IN-13 has high selectivity for targets over PDE1, PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11. PDE5-IN-13 is orally active .
loading...
    loading...
Cat. No.: HY-177298
CAS No.: 366444-83-9
Research Areas:  

Others

PDE5-IN-15 (compound 21) is a xanthine derivative and PDE5 inhibitor, with IC50 values of 0.002, 0.180, 2.85 and 2.22 μM against hPDE5, bPDE6, bPDE1 and hPDE3, respectively. PDE5-IN-15 has good oral bioavailability in dogs. PDE5-IN-15 can be used in research on male erectile dysfunction .
loading...
    loading...